AstraZeneca PLC (AZN) — Analyst outlook / Analyst consensus target is. Based on 41 analyst ratings, the consensus is bullish — 1 Strong Buy, 19 Buy, 15 Hold, 6 Sell.
The consensus price target is $105.50 (low: $103.00, high: $108.00), representing a downside of 48.4% from the current price $204.38.
Analysts estimate Earnings Per Share (EPS) of $8.21 and revenue of $53.12B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $1.14 vs est $8.21 (missed -86.1%). 2025: actual $13.20 vs est $9.16 (beat +44.1%). Analyst accuracy: 0%.
AZN Stock — 12-Month Price Forecast
$105.50
▼ -48.38% Downside
Average Price Target
Based on 41 Wall Street analysts offering 12-month price targets for AstraZeneca PLC, the average price target is $105.50, with a high forecast of $108.00, and a low forecast of $103.00.
The average price target represents a -48.38% change from the last price of $204.38.
Highest Price Target
$108.00
Average Price Target
$105.50
Lowest Price Target
$103.00
AZN Analyst Ratings
Buy
Based on 41 analysts giving stock ratings to AstraZeneca PLC in the past 3 months
EPS Estimates — AZN
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $1.14
vs Est $8.21
▼ 620.2% off
2025
Actual $13.20
vs Est $9.16
▲ 30.6% off
Profitability Outlook
Strong profitability with high earnings per share. EPS trend is improving.
Revenue Estimates — AZN
99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $54.073B
vs Est $53.118B
▲ 1.8% off
2025
Actual $58.739B
vs Est $58.648B
▲ 0.2% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
